Vertex Pharmaceuticals (VRTX) Inventory (2011 - 2026)

Vertex Pharmaceuticals has reported Inventory for 16 years, with the latest figure at $1.8 billion in Q2 2026.

• On a quarterly basis, Inventory rose 17.73% year-over-year to $1.8 billion in Q2 2026; TTM through Jun 2026 was $1.8 billion, a 17.73% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 39.94% from the prior year.
• Inventory was $1.8 billion for Q2 2026 at Vertex Pharmaceuticals, roughly flat from $1.8 billion in the prior quarter.
• The five-year high for Inventory was $1.8 billion in Q1 2026, with the low at $338.9 million in Q1 2022.
• Average Inventory over 5 years is $991.0 million, with a median of $863.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory advanced 13.4% in 2022, then jumped 77.41% in 2023.
• Over 5 years, Inventory stood at $460.6 million in 2022, then soared by 60.4% to $738.8 million in 2023, then jumped by 63.16% to $1.2 billion in 2024, then surged by 39.94% to $1.7 billion in 2025, then gained by 4.64% to $1.8 billion in 2026.
• The last three Inventory figures came in at $1.8 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.7 billion (Q4 2025), per Business Quant data.